Translation of the Philadelphia chromosome into therapy for CML.
By Brian J. Druker. Blood, 2008
670 citations recorded by the source corpus.
Subfields: Genetics, Hematology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/89aae05693d105982b1dce5fd714e4064f5659e6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers (2013, positive): “Importantly, virtually all CML patients harbor the BCR-ABL kinase fusion and respond to the small molecule kinase inhibitor, imatinib, representing one of the earliest examples of precision medicine in practice (6).”